Cardiac troponin I level in healthy newborn babies in Ilorin, North‑Central Nigeria

Main Article Content

Amudalat Issa
Mohammed Baba Abdulkadir
Olayinka R. Ibrahim
Habibat Suberu
Ruqayat Ronke Bakare
Ibraheem Sanusi
Omotayo Olukemi Adesiyun

Abstract

BACKGROUND: Cardiac troponins are reliable markers for the diagnosis of myocardial ischaemia. Cardiac troponin I is a valuable biomarker that has gained popularity across all ages including newborns. However, its usage in our environment in the paediatrics age group is limited probably because few studies have evaluated the normal levels in the healthy children. Hence, we determined the cardiac troponin I level in healthy term newborns.


METHODOLOGY: This was a cross‑sectional analytical study that involved 85 healthy term appropriate for gestational age newborns aged 24–72 h of life. The babies had relevant demographic parameters collected in a study pro forma. We determined the cardiac troponin I assay using enzyme‑linked immunosorbent assay (Enzyme linked immunosorbent assay method (ELISA)) method.


RESULTS: The median (interquartile range [IQR]) cardiac troponin I level was 0.79 (0.79–1.42) ng/ml. The cardiac troponin I level in male newborns, 1.05 (0.79–1.55) ng/ml, was higher but comparable with female newborns, 0.79 (0.79–1.00) ng/ml, P = 0.227. The cardiac troponin I increases with gestational age, P = 0.049. There was no relationship between cardiac troponin I level and birth weight, chronological age and mode of delivery (P > 0.05 in each).


CONCLUSION: The study demonstrated cardiac troponin I levels in healthy term Nigerian newborns with a significant relationship with gestational age.

Downloads

Download data is not yet available.

Article Details

How to Cite
Issa, A., Abdulkadir, M. B., Ibrahim, O. R., Suberu, H., Bakare, R. R., Sanusi, I., & Adesiyun, O. O. (2022). Cardiac troponin I level in healthy newborn babies in Ilorin, North‑Central Nigeria. Journal of The Medical Women’s Association of Nigeria, 6(1), 17-20. https://doi.org/10.60787/jmwan-v6i1-9
Section
Original Article
Author Biographies

Mohammed Baba Abdulkadir, Department of  Paediatrics and Child  Health, University of  Ilorin Teaching Hospita

Department of Paediatrics and Child Health, University of Ilorin, Ilorin, Kwara State, Nigeria

Omotayo Olukemi Adesiyun, Department of  Paediatrics and Child  Health, University of Ilorin Teaching Hospital

Department of Paediatrics and Child Health, University of Ilorin, Ilorin, Kwara State, Nigeria i

References

Vasan RS. Biomarkers of cardiovascular disease: Molecular basis and practical considerations. Circulation 2006;113:2335‑62.

Takeda S, Yamashita A, Maeda K, Maéda Y. Structure of the core domain of human cardiac troponin in the Ca(2+)‑saturated form.

Nature 2003;424:35‑41.

Larue C, Defacque‑Lacquement H, Calzolari C, Le Nguyen D, Pau B. New monoclonal antibodies as probes for human cardiac troponin I: Epitopic analysis with synthetic peptides. Mol Immunol 1992;29:271‑8.

Perry SV. Troponin T: Genetics, properties and function. J Muscle Res Cell Motil 1998;19:575‑602.

Apple FS, Collinson PO; IFCC Task Force on Clinical Applications of Cardiac Biomarkers. Analytical characteristics of high‑sensitivity cardiac troponin assays. Clin Chem 2012;58:54‑61.

Correale M, Nunno L, Ieva R, Rinaldi M, Maffei G, Magaldi R, et al. Troponin in newborns and pediatric patients. Cardiovasc Hematol Agents Med Chem 2009;7:270‑8.

Müller‑Bardorff M, Hallermayer K, Schröder A, Ebert C, Borgya A, Gerhardt W, et al. Improved troponin T ELISA specific for cardiac troponin T isoform: Assay development and analytical and clinical validation. Clin Chem 1997;43:458‑66.

Bodor GS, Porterfield D, Voss EM, Smith S, Apple FS. Cardiac troponin‑I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. Clin Chem 1995;41:1710‑5.

Rajakumar PS, Bhat BV, Sridhar MG, Balachander J, Konar BC, Narayanan P, et al. Cardiac enzyme levels in myocardial dysfunction in newborns with perinatal asphyxia. Indian J Pediatr 2008;75:1223‑5.

Tarkowska A, Furmaga‑Jabłońska W. The evaluation of diagnostic role of cardiac troponin T (cTnT) in newborns with heart defects. Scientific World Journal 2012;2012:682538.

Sobki SH, Saadeddin SM, Habbab MA. Cardiac markers used in the detection of myocardial injury. Saudi Med J 2000;21:843‑6.

McAuliffe F, Mears K, Fleming S, Grimes H, Morrison JJ. Fetal cardiac troponin I in relation to intrapartum events and umbilical artery pH. Am J Perinatol 2004;21:147‑52.

Türker G, Sarper N, Babaoğlu K, Gökalp AS, Duman C, Arisoy AE. Early prognostic significance of umbilical cord troponin I in critically ill newborns. Prospective study with a control group. J Perinat Med 2005;33:54‑9.

Pal P, Goel M. ECG changes in birth asphyxia and its correlation with cardiac troponin‑I. Int J Med Res Rev. 2015;3:400‑3.

Simović AM, Kosutić JLj, Prijić SM, Knezević JB, Vujić AJ, Stojanović ND. The role of biochemical markers as early indicators of cardiac damage and prognostic parameters of perinatal asphyxia. Vojnosanit Pregl 2014;71:149‑55.

Araújo K, da Silva J, Sañudo A, Kopelman B. Plasma concentrations of cardiac troponin I in newborn infants. Clin Chem 2004;50:1717‑8.

Teixeira RP, Neves AL, Guimarães H. Cardiac biomarkers in neonatology : BNP/NTproBNP, troponin I/T, CK‑MB and myoglobin – A systematic review. J Pediatr Neonatal Individ Med 2017;6:1‑18.

Bader D, Kugelman A, Lanir A, Tamir A, Mula E, Riskin A. Cardiac troponin I serum concentrations in newborns: A study and review of the literature. Clin Chim Acta 2006;371:61‑5.

Baum H, Hinze A, Bartels P, Neumeier D. Reference values for cardiac troponins T and I in healthy neonates. Clin Biochem 2004;37:1079‑82.